18 May 2020 | Views
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, Bengaluru talks about the ongoing COVID-19 crisis
"The world is waiting for a vaccine for COVID-19 but till the time it is developed, there is a need to conduct tests and build a treatment regime to save lives. Indian biotech sector worked quickly and came out with indigenous test kits. Today, more than 200,000 tests can be conducted using RT-PCR kits and soon over a million tests can be conducted using indigenous test kits. This is the time for all technologies to converge and biotech is role is very vital in this. COVID-19 is an emergency, the government needs to step up for such emergencies and look at long term planning."
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, Bengaluru